| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |